Tirzepatide has emerged as a groundbreaking medication for type 2 diabetes, offering promising results. However, the cost of this innovative drug and its availability have become key topics for patients and healthcare providers. While tirzepatide has been authorized by regulatory agencies, its high-priced nature presents a significant barrier to m